Soleno Therapeutics (SLNO) AGM 2024 summary

Opening remarks and agenda

• The meeting was called to order by the CFO, who introduced the board members, nominees, and key representatives present, including legal counsel and the Inspector of Elections.

• The agenda included electing one Class 1 Director, ratifying the appointment of the independent auditor, and approving amendments to the equity incentive plan.

• The meeting was conducted virtually, with voting procedures explained and proxies collected via email.

Board and executive committee updates

• The board consists of six members divided into three classes, with one Class 1 Director position up for election.

• Dr. Andrew Sinclair was nominated for re-election as Class 1 Director, recommended by the Nominating and Corporate Governance Committee.

Shareholder proposals

• Stockholders were asked to vote on three proposals: electing a Class 1 Director, ratifying Marcum LLP as independent auditor, and amending the 2014 Equity Incentive Plan.

• No additional director nominations were received from stockholders.